Tooze RM - Search Results

1

Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report.

Lacy SE, Barrans SL, Beer PA, Painter D, Smith AG, Roman E, Cooke SL, Ruiz C, Glover P, Van Hoppe SJL, Webster N, Campbell PJ, Tooze RM, Patmore R, Burton C, Crouch S, Hodson DJ. Lacy SE, et al. Among authors: tooze rm. Blood. 2020 May 14;135(20):1759-1771. doi: 10.1182/blood.2019003535. Blood. 2020. PMID: 32187361 Free PMC article.

2

The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research.

Smith A, Roman E, Howell D, Jones R, Patmore R, Jack A; Haematological Malignancy Research Network. Smith A, et al. Br J Haematol. 2010 Mar;148(5):739-53. doi: 10.1111/j.1365-2141.2009.08010.x. Epub 2009 Dec 1. Br J Haematol. 2010. PMID: 19958356 Free PMC article.

3

Whole genome expression profiling based on paraffin embedded tissue can be used to classify diffuse large B-cell lymphoma and predict clinical outcome.

Barrans SL, Crouch S, Care MA, Worrillow L, Smith A, Patmore R, Westhead DR, Tooze R, Roman E, Jack AS. Barrans SL, et al. Br J Haematol. 2012 Nov;159(4):441-53. doi: 10.1111/bjh.12045. Epub 2012 Sep 13. Br J Haematol. 2012. PMID: 22970711 Free article.

4

A microarray platform-independent classification tool for cell of origin class allows comparative analysis of gene expression in diffuse large B-cell lymphoma.

Care MA, Barrans S, Worrillow L, Jack A, Westhead DR, Tooze RM. Care MA, et al. Among authors: tooze rm. PLoS One. 2013;8(2):e55895. doi: 10.1371/journal.pone.0055895. Epub 2013 Feb 12. PLoS One. 2013. PMID: 23424639 Free PMC article.

5

SPIB and BATF provide alternate determinants of IRF4 occupancy in diffuse large B-cell lymphoma linked to disease heterogeneity.

Care MA, Cocco M, Laye JP, Barnes N, Huang Y, Wang M, Barrans S, Du M, Jack A, Westhead DR, Doody GM, Tooze RM. Care MA, et al. Among authors: tooze rm. Nucleic Acids Res. 2014 Jul;42(12):7591-610. doi: 10.1093/nar/gku451. Epub 2014 May 29. Nucleic Acids Res. 2014. PMID: 24875472 Free PMC article.

6

FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma.

Vogel MJ, Xie L, Guan H, Tooze RM, Maier T, Kostezka U, Maier HJ, Holzmann K, Chan FC, Steidl C, Reichel JB, Weitzer CD, Gehringer F, Kick AB, Cesarman E, Roshal M, Gascoyne RD, Möller P, Wirth T, Ushmorov A. Vogel MJ, et al. Among authors: tooze rm. Blood. 2014 Nov 13;124(20):3118-29. doi: 10.1182/blood-2014-07-590570. Epub 2014 Sep 17. Blood. 2014. PMID: 25232062 Free article.

7

Transferring genomics to the clinic: distinguishing Burkitt and diffuse large B cell lymphomas.

Sha C, Barrans S, Care MA, Cunningham D, Tooze RM, Jack A, Westhead DR. Sha C, et al. Among authors: tooze rm. Genome Med. 2015 Jul 1;7(1):64. doi: 10.1186/s13073-015-0187-6. eCollection 2015. Genome Med. 2015. PMID: 26207141 Free PMC article.

8

Cell-of-origin in diffuse large B-cell lymphoma: findings from the UK's population-based Haematological Malignancy Research Network.

Painter D, Barrans S, Lacy S, Smith A, Crouch S, Westhead D, Sha C, Patmore R, Tooze R, Burton C, Roman E. Painter D, et al. Br J Haematol. 2019 May;185(4):781-784. doi: 10.1111/bjh.15619. Epub 2018 Nov 8. Br J Haematol. 2019. PMID: 30408148 Free article. No abstract available.

9

Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy.

Sha C, Barrans S, Cucco F, Bentley MA, Care MA, Cummin T, Kennedy H, Thompson JS, Uddin R, Worrillow L, Chalkley R, van Hoppe M, Ahmed S, Maishman T, Caddy J, Schuh A, Mamot C, Burton C, Tooze R, Davies A, Du MQ, Johnson PWM, Westhead DR. Sha C, et al. J Clin Oncol. 2019 Jan 20;37(3):202-212. doi: 10.1200/JCO.18.01314. Epub 2018 Dec 3. J Clin Oncol. 2019. PMID: 30523719 Free PMC article.

10

Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial.

Davies A, Cummin TE, Barrans S, Maishman T, Mamot C, Novak U, Caddy J, Stanton L, Kazmi-Stokes S, McMillan A, Fields P, Pocock C, Collins GP, Stephens R, Cucco F, Clipson A, Sha C, Tooze R, Care MA, Griffiths G, Du MQ, Westhead DR, Burton C, Johnson PWM. Davies A, et al. Lancet Oncol. 2019 May;20(5):649-662. doi: 10.1016/S1470-2045(18)30935-5. Epub 2019 Apr 1. Lancet Oncol. 2019. PMID: 30948276 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74 results

Search Page